Glyco-engineering for biopharmaceutical production in moss bioreactors

The production of recombinant biopharmaceuticals (pharmaceutical proteins) is a strongly growing area in the pharmaceutical industry. While most products to date are produced in mammalian cell cultures, namely Chinese hamster ovary cells, plant-based production systems gained increasing acceptance o...

Descripción completa

Detalles Bibliográficos
Autores principales: Decker, Eva L., Parsons, Juliana, Reski, Ralf
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2014
Materias:
Plant Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4089626/
https://www.ncbi.nlm.nih.gov/pubmed/25071817
http://dx.doi.org/10.3389/fpls.2014.00346

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4089626/
https://www.ncbi.nlm.nih.gov/pubmed/25071817
http://dx.doi.org/10.3389/fpls.2014.00346

Ejemplares similares